Latest Blogs

Apr 30, 2024
Men in the oncology workforce, writes Dr. Khalid El Bairi, have a critical part to play in righting longstanding gender disparities in the field.
Apr 16, 2024
Following a HemOncFellows’ Network discussion on common questions aspiring and current fellows have about oncology fellowship, 10 participants, organizers, and members share practical advice that you can use in preparing for your fellowship.
Apr 09, 2024
How should an oncologist investigate a career change? How does one find their second or third job out of training? Here are some strategies to consider.
Apr 04, 2024
"To any medical students and residents who have a spark for oncology, I cannot recommend the VMP enough," said Zain Ahmad. "It is an experience that could change the trajectory of your career."
Subscribe to this column

ASCO Commentary

ASCO Commentary provides an interactive platform for ASCO’s organizational leadership and senior staff to connect directly to ASCO’s membership and the wider oncology community.

Oct 28, 2016
Dr. Richard L. Schilsky outlines the Society's Target Agent and Profiling Utilization Registry (TAPUR) Study and similar international protocols. A global data sharing platform could greatly accelerate our ability to learn about new uses for currently approved targeted anticancer drugs.
Nov 02, 2015
Chief Medical Officer Dr. Richard L. Schilsky answers your questions about this exciting new opportunity in health care policy and advocacy.
Oct 26, 2015
Personalized cancer care is not a new concept, but its application has been enabled and enhanced by a far greater understanding of the biological underpinnings of cancer than ever existed before.
Nov 12, 2014
By Richard L. Schilsky, MD, FASCO, Chief Medical Officer of ASCO. During the past six weeks I’ve had the opportunity to attend cancer meetings in four countries on three continents. In September, I represented ASCO at the annual meeting of the Chinese Society of Clinical Oncology (CSCO) in Xiamen,...
Feb 06, 2014
By Richard L. Schilsky, MD, FASCO, Chief Medical Officer of ASCO. I’ve been a regular attendee of the Gastrointestinal Cancers Symposium since it began 11 years ago. This year’s meeting was among the very best with record attendance, superb educational talks and keynote lectures, multidisciplinary...

Pages